6558-62-9 Usage
Uses
1-METHYL-IMIDAZO[1,5-A]PYRIDINE is not used for any specific applications in industries, as it is a harmful substance with carcinogenic, mutagenic, and genotoxic effects. However, efforts to minimize exposure to 1-MeIP are crucial for public health.
Used in Public Health:
1-METHYL-IMIDAZO[1,5-A]PYRIDINE is a concern for public health due to its carcinogenic properties.
1-METHYL-IMIDAZO[1,5-A]PYRIDINE is used as a reference for [reason to minimize exposure] because it is linked to an increased risk of developing cancer, particularly in the colon, prostate, and lung.
Efforts to minimize exposure to 1-METHYL-IMIDAZO[1,5-A]PYRIDINE include:
1. Modifying cooking methods to avoid high-temperature cooking processes such as grilling, smoking, or charbroiling, which can lead to the formation of 1-MeIP in certain meats and fish.
2. Raising awareness about the potential health risks associated with exposure to 1-MeIP, particularly in relation to tobacco smoke and overcooked or charred foods.
Check Digit Verification of cas no
The CAS Registry Mumber 6558-62-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,5 and 8 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 6558-62:
(6*6)+(5*5)+(4*5)+(3*8)+(2*6)+(1*2)=119
119 % 10 = 9
So 6558-62-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2/c1-7-8-4-2-3-5-10(8)6-9-7/h2-6H,1H3
6558-62-9Relevant academic research and scientific papers
El-Abadelah, Mustafa M.,Awwadi, Firas F.,Abdullah, Ahmad H.,Voelter, Wolfgang
, p. 559 - 565 (2020)
The synthesis of 2,2′-(Imidazo[1,5-a]pyridine-1,3-diyl)bis(2-hydroxy-1H-indene-1,3(2H)-dione) (11) is achieved by reaction of imidazo[1,5-a]pyridine (7) with two equivalents of ninhydrin (1) at room temperature. The structure of this new 1,3-bis-adduct 11 is evidenced from HRMS and NMR spectral data and confirmed by single-crystal X-ray crystallography. Employment of equimolar amounts of 1 and 7 gave a separable mixture of the respective 1- A nd 3-monomeric adducts (9, 10).
Preparation method of N- phenyl-2-aminopyrimidine compound and its application
-
Paragraph 0129; 0139; 0140; 0141, (2017/04/28)
The invention relates to a new N- phenyl-2-aminopyrimidine compound and a medicine composition containing the compound; the N- phenyl-2-aminopyrimidine compound is applied to treat related disease or symptoms of epidermal growth factor receptor (EGFR), such as treat or improve abnormal cell proliferative disease like cancer.
